These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 11106255)
1. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Gilbert JA; Frederick LM; Ames MM Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255 [TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines. Gilbert JA; Frederick LM; Pobst LJ; Ames MM Biochem Pharmacol; 2005 Apr; 69(8):1159-66. PubMed ID: 15794936 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation. El-Bayoumy K; Rose DP; Papanikolaou N; Leszczynska J; Swamy MV; Rao CV Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568 [TBL] [Abstract][Full Text] [Related]
4. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288 [TBL] [Abstract][Full Text] [Related]
5. Effects of dibutyryl cyclic adenosine 3':5'-monophosphate on the growth of cultured human small-cell lung carcinoma and the specific cellular activity of L-dopa decarboxylase. Francis J; Thompson R; Bernal SD; Luk GD; Baylin SB Cancer Res; 1983 Feb; 43(2):639-45. PubMed ID: 6293702 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of magainin analogues against human lung cancer cell lines. Ohsaki Y; Gazdar AF; Chen HC; Johnson BE Cancer Res; 1992 Jul; 52(13):3534-8. PubMed ID: 1319823 [TBL] [Abstract][Full Text] [Related]
7. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma. Strassheim D; Shafer SH; Phelps SH; Williams CL Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148 [TBL] [Abstract][Full Text] [Related]
8. Elevated aromatic-L-amino acid decarboxylase in human carcinoid tumors. Gilbert JA; Bates LA; Ames MM Biochem Pharmacol; 1995 Sep; 50(6):845-50. PubMed ID: 7575647 [TBL] [Abstract][Full Text] [Related]
9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
10. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach. Tong AW; Lee J; Stone MJ Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911 [TBL] [Abstract][Full Text] [Related]
11. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922 [TBL] [Abstract][Full Text] [Related]
12. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate. Curt GA; Jolivet J; Carney DN; Bailey BD; Drake JC; Clendeninn NJ; Chabner BA J Clin Invest; 1985 Oct; 76(4):1323-9. PubMed ID: 2414316 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors. Kidd M; Schally AV; Pfragner R; Malfertheiner MV; Modlin IM Cancer; 2008 Mar; 112(6):1404-14. PubMed ID: 18224665 [TBL] [Abstract][Full Text] [Related]
14. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells. Krystal GW; Honsawek S; Kiewlich D; Liang C; Vasile S; Sun L; McMahon G; Lipson KE Cancer Res; 2001 May; 61(9):3660-8. PubMed ID: 11325836 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365 [TBL] [Abstract][Full Text] [Related]
16. Interaction of recombinant human tumor necrosis factor and etoposide in human lung cancer cell lines. Doyle LA; Hamburger AW; Goldstein LH; Park HJ Mol Biother; 1990 Sep; 2(3):169-74. PubMed ID: 2171561 [TBL] [Abstract][Full Text] [Related]
17. Cell type-specific differences in metabolic activation of N-nitrosodiethylamine by human lung cancer cell lines. Schuller HM; Falzon M; Gazdar AF; Hegedus T IARC Sci Publ; 1987; (84):138-40. PubMed ID: 2824357 [TBL] [Abstract][Full Text] [Related]
18. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture. Baylin SB; Abeloff MD; Goodwin G; Carney DN; Gazdar AF Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807 [TBL] [Abstract][Full Text] [Related]
19. A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines. Güzey M; DeLuca HF Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):3-18. PubMed ID: 9434311 [TBL] [Abstract][Full Text] [Related]
20. Differential response to treatment with the bis(ethyl)polyamine analogues between human small cell lung carcinoma and undifferentiated large cell lung carcinoma in culture. Casero RA; Ervin SJ; Celano P; Baylin SB; Bergeron RJ Cancer Res; 1989 Feb; 49(3):639-43. PubMed ID: 2535963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]